Related Experiment Videos
p21WAF1/CIP1 interacts with protein kinase CK2
C Götz1, P Wagner, O G Issinger
1Institute of Medical Biochemistry, University of the Saarland, Homburg, Germany.
Abstract:
p21WAF1/CIP1 which belongs to a class of regulatory proteins that interact with cyclin dependent kinases is a potent inhibitor of these kinases. The inhibition of the cyclin dependent kinases induces an arrest of cells in the G phase of the cell cycle. In addition p21WAF1/CIP1 associates with PCNA and inhibits DNA replication. Here, we show that p21WAF1/CIP1 binds to the regulatory beta-subunit of protein kinase CK2 but not to the catalytic alpha-subunit. Binding of p21WAF1/CIP1 down regulates the kinase activity of CK2 with respect to the phosphorylation of the beta-subunit of CK2, casein and the C-terminus of p53. This study demonstrates a new binding partner for the regulatory beta-subunit of protein kinase CK2 which regulates the activity of the holoenzyme.
Insights
The p21 protein binds to protein kinase CK2, inhibiting its activity and affecting cell cycle regulation. This discovery reveals a new interaction impacting DNA replication and cell growth.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Enzyme Kinetics
Background:
- p21WAF1/CIP1 is a cell cycle inhibitor that interacts with cyclin-dependent kinases and PCNA.
- Protein kinase CK2 (CK2) is a multi-subunit enzyme involved in various cellular processes.
Purpose of the Study:
- To investigate the interaction between p21WAF1/CIP1 and protein kinase CK2.
- To determine the functional consequences of this interaction on CK2 activity.
Main Methods:
- Co-immunoprecipitation assays to detect protein binding.
- In vitro kinase assays to measure CK2 activity.
Main Results:
- p21WAF1/CIP1 specifically binds to the regulatory beta-subunit of CK2, not the catalytic alpha-subunit.
- Binding of p21WAF1/CIP1 downregulates CK2 activity towards its beta-subunit, casein, and the C-terminus of p53.
Conclusions:
- p21WAF1/CIP1 is identified as a novel binding partner for the CK2 beta-subunit.
- This interaction modulates the holoenzyme activity of CK2, suggesting a new regulatory mechanism in cellular processes.